Cytochrome P450 (CYP) 4Fs constitute a subgroup of the cytochrome P450 superfamily and are involved in cellular protection and metabolism of numerous molecules, including drugs, toxins, and eicosanoids. CYP4Fs are widely distributed in rat brain with each isoform having a unique distribution pattern throughout different brain regions. The present study shows that traumatic brain injury (TBI) triggers inflammation and elicits changes in mRNA expression of CYP4Fs in the frontal and occipital lobes and the hippocampus. At 24 h post-injury, almost all CYP4F mRNA expression is suppressed compared with sham control throughout these three regions, while at 2 weeks post-injury, all CYP4F mRNAs increase, reaching levels higher than those at 24 h post-injury or uninjured controls. These changes in CYP4F levels inversely correlate with levels of leukotriene B4 (LTB4) levels in the brain following injury at the same time points. TBI also causes changes in CYP4F protein expression and localization around the injury site. CYP4F1 and CYP4F6 immunoreactivity increases in surrounding astrocytes, while CYP4F4 immunoreactivity shifts from endothelia of cerebral vessels to astrocytes.
Get full access to this article
View all access options for this article.
References
1.
AmaralS.L., MaierK.G., SchippersD.N., RomanR.J., GreeneA.S.2003. CYP4A metabolites of arachidonic acid and VEGF are mediators of skeletal muscle angiogenesis. Am. J. Physiol. Heart Circ. Physiol., 284:1528–1535.
2.
AnderssonS., DavisD.L., DahlbackH., JornvallH., RussellD.W.1989. Cloning, structure, and expression of the mitochondrial cytochrome P-450 sterol 26–hydroxylase, a bile acid biosynthetic enzyme. J. Biol. Chem., 264:8222–8229.
3.
BoehmeC.L., StrobelH.W.2001. In vitro metabolism of chlorpromazine by cytochrome P4504F4 and 4F5 and the inhibitory effect of impramine. Neurotoxicity Res., 3:329–337.
4.
ButterfieldT.A., BestT.M., MerrickM.A.2006. The dual roles of neutrophils and macrophages in inflammation: a critical balance between tissue damage and repair. J. Athl. Train., 41:457–465.
5.
BylundJ., HarderA.G., MaierK.G., RomanR.J., HarderD.R.2003. Leukotriene B4 omega-side chain hydroxylation by CYP4F5 and CYP4F6. Arch. Biochem. Biophys., 412:34–41.
6.
CartierL., HartleyO., Dubois-DauphinM., KrauseK.H.2005. Chemokine receptors in the central nervous system: role in brain inflammation and neurodegenerative diseases. Brain Res. Brain Res. Rev., 48:16–42.
7.
ChengJ.B., LevineM.A., BellN.H., MangelsdorfD.J., RussellD.W.2004. Genetic evidence that the human CYP2R1 enzyme is a key vitamin D 25–hydroxylase. Proc. Natl. Acad. Sci. USA, 101:7711–7715.
8.
ChomczynskiP.1993. A reagent for the single-step simultaneous isolation of RNA, DNA and proteins from cell and tissue samples. Biotechniques, 15:532–534536–537.
9.
CuiX., KalsotraA., RobidaA.M., MatzilevichD., MooreA.N., BoehmeC.L., MorganE.T., DashP.K., StrobelH.W.2003. Expression of cytochromes P450 4F4 and 4F5 in infection and injury models of inflammation. Biochim. Biophys. Acta, 1619:325–331.
10.
EllisE.F., WrightK.F., WeiE.P., KontosH.A. 1981. Cyclooxygenase products of arachidonic acid metabolism in cat cerebral cortex after experimental concussive brain injury. J. Neurochem, 37:892–896.
11.
FadenA.I., DemediukP., PanterS.S., VinkR.1989. The role of excitatory amino acids and NMDA receptors in traumatic brain injury. Science, 244:798–800.
12.
Frontczak-BaniewiczM., WalskiM.2002. Non-sprouting angiogenesis in neurohypophysis after traumatic injury of the cerebral cortex. Electron-microscopic studies. Neurol. Endocrinol. Lett., 23:396–404.
13.
GhirnikarR.S., LeeY.L., EngL.F.1998. Inflammation in traumatic brain injury: role of cytokines and chemokines. Neurochem. Res., 23:329–340.
14.
GuengerichF.P.2003. Cytochromes P450, drugs, and diseases. Mol. Interv., 3:194–204.
15.
HoaglandK.M., MaierK.G., MorenoC., YuM., RomanR.J.2001. Cytochrome P450 metabolites of arachidonic acid: novel regulators of renal function. Nephrol. Dial. Transplant., 16:2283–2285.
JinR., KoopD.R., RaucyJ.L., LaskerJ.M.1998. Role of human CYP4F2 in hepatic catabolism of the proinflammatory agent leukotriene B4. Arch. Biochem. Biophys., 359:89–98.
18.
KalsotraA., AnakkS., BoehmeC.L., StrobelH.W.2002. Sexual dimorphism and tissue specificity in the expression of CYP4F forms in Sprague Dawley rats. Drug Metab. Dispos., 30:1022–1028.
19.
KalsotraA., TurmanC.M., KikutaY., StrobelH.W.2004. Expression and characterization of human cytochrome P450 4F11: Putative role in the metabolism of therapeutic drugs and eicosanoids. Toxicol. Appl. Pharmacol., 199:295–304.
20.
KawashimaH., StrobelH.W.1995. cDNA cloning of three new forms of rat brain cytochrome P450 belonging to the CYP4F subfamily. Biochem. Biophys. Res. Commun., 217:1137–1144.
21.
KawashimaH., SequeiraD.J., NelsonD.R., StrobelH.W.1996. Genomic cloning and protein expression of a novel rat brain cytochrome P-450 CYP2D18* catalyzing imipramine N-demethylation. J. Biol. Chem., 271:28176–28180.
22.
KawashimaH., KusunoseE., ThompsonC.M., StrobelH.W.1997. Protein expression, characterization, and regulation of CYP4F4 and CYP4F5 cloned from rat brain. Arch. Biochem. Biophys., 347:148–154.
23.
KikutaY., KusunoseE., EndoK., YamamotoS., SogawaK., Fujii-KuriyamaY., KusunoseM.1993. A novel form of cytochrome P-450 family 4 in human polymorphonuclear leukocytes. cDNA cloning and expression of leukotriene B4 omega-hydroxylase. J. Biol. Chem., 268:9376–9380.
24.
LaskerJ.M., ChenW.B., WolfI., BloswickB.P., WilsonP.D., PowellP.K.2000. Formation of 20–hydroxyeicosatetraenoic acid, a vasoactive and natriuretic eicosanoid, in human kidney. Role of Cyp4F2 and Cyp4A11. J. Biol. Chem., 275:4118–4126.
MorganE.T.2001. Regulation of cytochrome p450 by inflammatory mediators: why and how? Drug Metab. Dispos., 29:207–212.
27.
MyerD.J., GurkoffG.G., LeeS.M., HovdaD.A., SofroniewM.V.2006. Essential protective roles of reactive astrocytes in traumatic brain injury. Brain, 129:2761–2772.
28.
NicholsonT.E., RentonK.W.1999. Modulation of cytochrome P450 by inflammation in astrocytes. Brain Res., 827:12–18.
29.
OttL., McClainC.J., GillespieM., YoungB.1994. Cytokines and metabolic dysfunction after severe head injury. J. Neurotrauma, 11:447–472.
30.
PoloyacS.M., ZhangY., BiesR.R., KochanekP.M., GrahamS.H.2006. Protective effect of the 20–HETE inhibitor HET0016 on brain damage after temporary focal ischemia. J. Cereb. Blood Flow Metab., 26:1551–1561.
31.
SaitoT., StrobelH.W.1981. Purification to homogeneity and characterization of a form of cytochrome P-450 with high specificity for benzo[alpha]pyrene from beta-naphthoflavone-pretreated rat liver microsomes. J. Biol. Chem., 256:984–988.
32.
SchuhmannM.U., MokhtarzadehM., StichtenothD.O., SkardellyM., KlingeP.M., GutzkiF.M., SamiiM., BrinkerT.2003. Temporal profiles of cerebrospinal fluid leukotrienes, brain edema and inflammatory response following experimental brain injury. Neurol. Res., 25:481–491.
33.
ShohamiE., ShapiraY., SidiA., CotevS.1987. Head injury induces increased prostaglandin synthesis in rat brain. J. Cereb. Blood Flow Metab., 7:58–63.
34.
SmithP.K., KrohnR.I., HermansonG.T., MalliaA.K., GartnerF.H., ProvenzanoM.D., FujimotoE.K., GoekeN.M., OlsonB.J., KlenkD.C.1985. Measurement of protein using bicinchoninic acid. Anal. Biochem., 150:76–85.
35.
WilliamsJ.F.1991. Cytochrome P450 isoforms. Regulation during infection, inflammation and by cytokines. J. Fla. Med. Assoc., 78:517–519.
36.
XuF., FalckJ.R., Ortiz de MontellanoP.R., KroetzD.L.2004. Catalytic activity and isoform-specific inhibition of rat cytochrome p450 4F enzymes. J. Pharmacol. Exp. Ther., 308:887–895.
37.
XuJ.A., HsuC.Y., LiuT.H., HoganE.L., PerotP.L.Jr, TaiH.H.1990. Leukotriene B4 release and polymorphonuclear cell infiltration in spinal cord injury. J. Neurochem., 55:907–912.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
